biotech
STAT is a leading source of news and analysis on biotechnology. Here you will find coverage of the latest research developments, the regulatory landscape, and the business of biotech.
This page also includes articles about the ethical implications of biotechnology, the challenges of commercializing new biotech products, and the future of the life sciences industry.
Latest
BioNTech is having its Pfizer moment
Novo is building a really big computer
STAT Plus: Contineum Therapeutics files for IPO
STAT Plus: What happens when an approved drug doesn’t work?
STAT Plus: Is CAR-T safe for early-stage patients?
STAT Plus: Geron’s resurgence might have been short-lived
STAT Plus: When did Wall Street sour on Lilly’s Alzheimer’s drug?
All Coverage
advertisement
